Cameron Turtle

SYRE

Cameron Turtle serves as director, officer: Chief Executive Officer at Spyre Therapeutics, Inc. (SYRE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

7 trades

$4.66M

Net Position

Net Seller

$4.66M

Companies Traded

SYRE

Active Period

Nov 2025 – Mar 2026

7 total trades

Most Recent

Sell SYRE

Mar 3, 2026 · $1.27M

Cameron Turtle's Insider Trading at Spyre Therapeutics, Inc. (SYRE)

Buys

0 · $0.00

Sells

7 · $4.66M

Total Shares Bought

Total Shares Sold

150,000

SYRE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 3, 2026↗	Sell	30,000	$42.19	$1.27M	651,640
Feb 4, 2026↗	Sell	15,000	$32.80	$492.0K	671,583
Feb 2, 2026↗	Sell	15,000	$32.80	$492.0K	0
Jan 6, 2026↗	Sell	15,000	$30.68	$460.1K	674,198
Jan 2, 2026↗	Sell	15,000	$30.68	$460.1K	0
Dec 1, 2025↗	Sell	15,000	$29.02	$435.4K	0
Nov 3, 2025↗	Sell	45,000	$23.33	$1.05M	0

Related Insiders

Scott L Burrows

officer: Chief Financial Officer

SYRESell · Mar 3, 2026

Scott L Burrows

Chief Financial Officer

SYRESell · Sep 2, 2025

Explore More Insider Trading Data

SYRE Insider Trading Activity

View all insider trades at Spyre Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity